CREDIT: GIORGIA MENEGONI, SAPIENZA, UNIVERSITY OF ROME Bethesda, MD – In a new animal study examining Alzheimer’s disease, researchers found that disease progression could be slowed by decreasing neuroinflammation in the brain before memory problems and cognitive impairment were apparent. The new findings point to the importance of developing therapies that target very early stages...
Month: <span>May 2020</span>
Post
Immunotherapy before surgery could advance care of an aggressive form of skin cancer
In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic evidence of cancer in nearly half of the study participants undergoing surgery. In patients whose tumors respond, this treatment...
Post
Treating Epilepsy with Stimulated Seizures
By Sara Ryding, B.Sc.Reviewed by Emily Henderson, B.Sc. Epilepsy is a common neurological disorder that affects 65 million people around the world. Despite being so common, it is generally not well understood and around one-third of those afflicted cannot control their condition with medication. One of the emerging ways to deal with epilepsy is to...
Post
COVID-19: Stem Cell Therapy Shows 83% Survival of Coronavirus Patients, Study Found
By Tiziana Celine Tech Times Doctors are hoping stem cell therapy may be a weapon in the fight against coronavirus. Regenerative medicine employer Mesoblast introduced a 300-person trial on Friday, Apr. 24, to decide whether or not stem cell treatments will work in COVID-19 patients tormented by severe lung inflammation. The treatments had been intravenous...
Post
Molecules identified that reverse cellular aging process
By Nick Lavars Central to a lot of scientific research into aging are tiny caps on the ends of our chromosomes called telomeres. These protective sequences of DNA grow a little shorter each time a cell divides, but by intervening in this process, researchers hope to one day regulate the process of aging and the...
Post
LSD “off-switch” developed by psychedelic pharmaceutical company
By Rich Haridy Psychedelic pharmaceutical company MindMed has announced the development of a novel compound designed to stop the effects of an LSD experience. The compound is claimed to function as an “off-switch” for LSD, allowing clinicians a way to make psychedelic therapy sessions safer if patients become uncomfortable. The new announcement comes several weeks...
Post
Researchers identify key mechanisms involved in pulmonary fibrosis development
by Charité – Universitätsmedizin Berlin CT images and tissue sections show how healthy, air-filled tissue is replaced by thickened, stiff connective tissue. Credit: Leitz/Charité Working alongside research groups from Heidelberg, researchers from Charité – Universitätsmedizin Berlin have elucidated the novel disease processes involved in the development of pulmonary fibrosis. They were able to show that...
Post
Blood test offers early warning of chemotherapy-related heart problems
by Experimental Biology which chemotherapies can cause cardiotoxicity. The research team identified biomarkers and miRNAs that can provide early warning when this process is underway. Credit: Hari Vishal Lakhani, Marshall University Scientists have identified a collection of biomarkers that together signal that a person’s cancer treatment may be harming their heart. After further validation, the...
Post
Discovery: Scientists find for the first time how the eyes drain cellular waste and debris
by Delthia Ricks , Medical Xpress Just as the brain is a privileged organ, so too are the eyes. Often poetically called the windows to the soul, a unique set of studies has begun to regard the eyes in another way. Like the brain, the eyes lack the classic lymphatic vessels responsible for the circulation...
Post
Parkinson’s disease may start in the gut
by Karolinska Institutet Researchers at Karolinska Institutet in Sweden and the University of North Carolina in the USA have mapped out the cell types behind various brain disorders. The findings are published in Nature Genetics and offer a roadmap for the development of new therapies to target neurological and psychiatric disorders. One interesting finding was...